We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Avanade Brings Advances in Patient Care to M.D. Anderson with Improved Systems for Electronic Medical Records

EMR solution integrates clinical data with patient-specific information in a move towards personalized medicine for cancer patients.
News

Duke Integrative Medicine Opens a Center Dedicated to Treating the Whole Person

The facility will operate as a living laboratory to explore and demonstrate models of care by offering patients an approach to treat the whole person.
News

Dynal Bead Introduces Immunoassay Bead for IVD Applications

This bead type has been developed to provide highly precise immobilization of small antigens to the surface of the beads.
News

Bruker Daltonics and HealthLinx Expand Biomarker Discovery Collaboration

The companies with further develop biomarkers for a number of pregnancy complications.
News

Rules-Based Medicine and Multiplex Biosciences Merge

Merger extends R&D capabilities, product expertise and expands customer base.
News

Introgen Acquires Rights to New Nanotechnology Systems

Targeted nanoparticles used to deliver proteins, polypeptides and peptides.
News

onCore UK Licenses LabVantage's Sapphire™ BioBanking Solution to Support its Ambitious Cancer Biosample Resource

onCore UK will create and run a national biosample resource, collecting and storing tissue and blood samples donated by patients.
News

Kimball Genetics Launches the Warfarin Sensitivity DNA Test for Research

The Warfarin Sensitivity DNA Test determines the presence of specific variations in the CYP2C9 and VKORC1 genes that confer sensitivity to warfarin.
News

Genzyme Launches Cystic Fibrosis Gene Sequencing Test

CF gene sequencing detects the most common mutations, as well as less common mutations not included in the available mutation panels.
News

Myriad Genetics Sponsors Clinical Trial in Pancreatic Cancer

The trial will enroll patients with previously untreated, advanced or recurrent pancreatic cancer and a mutation in the BRCA2 gene.
Advertisement